{"@context":["https://www.w3.org/2018/credentials/v1","https://w3id.org/security/suites/jws-2020/v1"],"id":"https://data.deqar.eu/report/10942","type":["VerifiableCredential","VerifiableAttestation","VerifiableAccreditation","DiplomaVerifiableAccreditation"],"issuer":"did:ebsi:zk4bhCepWSYp9RhZkRPiwUL","issued":"2012-09-01T00:00:00Z","credentialSubject":{"authorizationClaims":{"accreditationType":"http://data.europa.eu/snb/accreditation/e57dddfcf3","decision":"positive","report":["http://backend.deqar.eu/reports/NVAO/20191025_1627_504ddfd29449e_rapport%20KULeuven%20Farmaceutische%20Wetenschappen.pdf","http://backend.deqar.eu/reports/NVAO/20191025_1627_504ddfd29449e_besluit%20KULeuven%20master%20Master%20of%20Science%20in%20de%20geneesmiddelenontwikkeling.pdf"],"limitQualification":[{"title":"Drug Development","alternativeLabel":["Geneesmiddelenontwikkeling"],"EQFLevel":"http://data.europa.eu/snb/eqf/7"}],"id":"https://data.deqar.eu/report/10942#subject=did:ebsi:zx23VeYxC5oGUWZ1SUSLjqL","limitJurisdiction":["http://publications.europa.eu/resource/authority/atu/BEL_CGG_VLA"]},"id":"did:ebsi:zx23VeYxC5oGUWZ1SUSLjqL"},"issuanceDate":"2012-09-01T00:00:00Z","validFrom":"2012-09-01T00:00:00Z","expirationDate":"2020-09-30T00:00:00Z","credentialSchema":{"id":"https://api.preprod.ebsi.eu/trusted-schemas-registry/v1/schemas/0x13d597f8495e6b6e3d0c072218756a1bcc3ea50ebeb3ab4c3944bd400e0c3c6a","type":"FullJsonSchemaValidator2021"},"proof":{"type":"JsonWebSignature2020","creator":"did:ebsi:zk4bhCepWSYp9RhZkRPiwUL","created":"2026-04-24T07:16:36Z","verificationMethod":"did:ebsi:zk4bhCepWSYp9RhZkRPiwUL","jws":"eyJiNjQiOmZhbHNlLCJjcml0IjpbImI2NCJdLCJhbGciOiJFUzI1NksifQ..zsBqOZbqcFWqEMh1j8Tg8IeeLPwUiRCG8GMNCLCx-KFnyo_tBHecuaDEbmxg2DtgD5Am-gAiH7_49JOBO8AZwg"}}